Equities Analysts Offer Predictions for TRVI FY2024 Earnings
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – HC Wainwright increased their FY2024 earnings per share (EPS) estimates for Trevi Therapeutics in a research report issued on Monday, March 10th. HC Wainwright analyst O. Livnat now anticipates that the company will post earnings of ($0.48) per share for the year, up from their previous forecast […]
